Thursday January 18th 2018

Report: Biogen draws takeover interest from Allergan, Merck

Less than two weeks after the CEO of Cambridge-based Biogen (Nasdaq: BIIB) announced plans to step down, reports surfaced that two big drugmakers are interested in buying the company. The Wall Street Journal reported this afternoon, citing unnamed sources, that New Jersey-based Merck& Co. (NYSE: MRK) and Irish drugmaker Allergan (NYSE: AGN) are among the companies considering a buy of the company known for its multiple sclerosis drugs. Shares soared on the news, climbing nearly 10 percent on the… (Source: bizjournals.com Health Care:Biotechnology headlines)

Visit source: 

Report: Biogen draws takeover interest from Allergan, Merck

Leave a Comment

More from category

6,000-year-old track record for healing leaky gut
6,000-year-old track record for healing leaky gut

When I was traveling in India, I had the privilege of studying Ayurvedic medicine with traditional Master Healers. [Read More]

Study shows high-salt diet causes dementia in mice
Study shows high-salt diet causes dementia in mice

A high-salt diet reduces resting blood flow to the brain and causes dementia in mice, according to a new study by [Read More]

What you should know about neurosarcoidosis
What you should know about neurosarcoidosis

A look at neurosarcoidosis, an inflammatory disease that can affect most organs in the body. Included is detail on [Read More]

Depression and fatigue in multiple sclerosis: relation to exposure to violence and cerebrospinal fluid immunomarkers – Brenner P, Granqvist M, K…
Depression and fatigue in multiple sclerosis: relation to exposure to violence and cerebrospinal fluid immunomarkers – Brenner P, Granqvist M, K…

Multiple sclerosis (MS) is a neuroinflammatory condition characterized by chronic dysregulation of immune responses [Read More]

Your NEJM Group Today: MS Review / HIV PrEP for Women / Texas Medical Director Opportunity
Your NEJM Group Today: MS Review / HIV PrEP for Women / Texas Medical Director Opportunity

Here's what we selected for you today: NEJM Clinical Practice Center: Review: A number of interventions to modify the [Read More]